| Cav1 | Caveolin-1 |
| Cav2 | Caveolin-2 |
| Cav3 | Caveolin-3 |
| DGC | Dystrophin glycoprotein complex |
| DMD | Duchene muscular dystrophy |
| CSD | Caveolin scaffolding domain |
| PtdIn(4,5)P2 | Phosphatidylinositol (4,5)-bisphosphate |
| ERK1/2 | Extracellular signal-regulated kinase 1 and 2 |
| EGFR | Epidermal growth factor receptors |
| Grb2 | Growth factor receptor-bound protein 2 |
| MAPK | Mitogen-activated protein kinases |
| Atg12 | Autophagy related 12 |
| SV40 | Simian virus 40 |
| NOS | Nitric oxide synthases |
| DYSF | Dysferlin |
| LGMD2B | Limb-girdle muscular dystrophy type 2B |
| DM | Distal Myopathy |
| MM | Miyoshi myopathy |
| PDGF | Platelet-derived growth factor |
| NOS | Nitric oxide synthases |
| DHPRs | Dihydropyridine receptors |
| LQT9 | Long QT Syndrome 9 |
| RYRs | Ryanodine receptors |
| IRS1 | Insulin receptor substrate 1 |
| PFK-M | Phosphofructokinase-M |
| GLUT4 | Glucose transporter type 4 |
| βAR | Beta-adrenergic receptors |
| LRP1 | Lipoprotein receptor-related protein 1 |
| NMJs | Neuromuscular junctions |
| AChRs | Acetylcholine receptors |
| MuSK | Muscle-specific kinase |
| RMD | Rippling muscle disease |
| LGMD | Limb-girdle muscular dystrophy |
| RMD-2 | Rippling Muscle Disease-2 |
| CK | Creatine kinase |